Accuray Earnings Calls
| Release date | May 06, 2026 |
| EPS estimate | -$0.0500 |
| EPS actual | -$0.0900 |
| EPS Surprise | -80.00% |
| Revenue estimate | 111.9M |
| Revenue actual | 104.845M |
| Revenue Surprise | -6.30% |
| Release date | Feb 04, 2026 |
| EPS estimate | -$0.108 |
| EPS actual | -$0.110 |
| EPS Surprise | -2.23% |
| Revenue estimate | 100.861M |
| Revenue actual | 102.241M |
| Revenue Surprise | 1.37% |
| Release date | Nov 05, 2025 |
| EPS estimate | -$0.0100 |
| EPS actual | -$0.180 |
| EPS Surprise | -1,700.00% |
| Revenue estimate | 122.9M |
| Revenue actual | 93.942M |
| Revenue Surprise | -23.56% |
| Release date | Aug 13, 2025 |
| EPS estimate | $0.0300 |
| EPS actual | $0.0103 |
| EPS Surprise | -65.63% |
| Revenue estimate | 92.95M |
| Revenue actual | 127.543M |
| Revenue Surprise | 37.22% |
Last 4 Quarters for Accuray
Below you can see how ARAY performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.
| Release date | Aug 13, 2025 |
| Price on release | $1.49 |
| EPS estimate | $0.0300 |
| EPS actual | $0.0103 |
| EPS surprise | -65.63% |
| Date | Price |
|---|---|
| Aug 07, 2025 | $1.32 |
| Aug 08, 2025 | $1.39 |
| Aug 11, 2025 | $1.36 |
| Aug 12, 2025 | $1.48 |
| Aug 13, 2025 | $1.49 |
| Aug 14, 2025 | $1.46 |
| Aug 15, 2025 | $1.40 |
| Aug 18, 2025 | $1.62 |
| Aug 19, 2025 | $1.51 |
| 4 days before | 12.88% |
| 4 days after | 1.34% |
| On release day | -2.01% |
| Change in period | 14.39% |
| Release date | Nov 05, 2025 |
| Price on release | $1.45 |
| EPS estimate | -$0.0100 |
| EPS actual | -$0.180 |
| EPS surprise | -1,700.00% |
| Date | Price |
|---|---|
| Oct 30, 2025 | $1.38 |
| Oct 31, 2025 | $1.41 |
| Nov 03, 2025 | $1.40 |
| Nov 04, 2025 | $1.38 |
| Nov 05, 2025 | $1.45 |
| Nov 06, 2025 | $1.22 |
| Nov 07, 2025 | $1.17 |
| Nov 10, 2025 | $1.17 |
| Nov 11, 2025 | $1.17 |
| 4 days before | 5.07% |
| 4 days after | -19.31% |
| On release day | -15.86% |
| Change in period | -15.22% |
| Release date | Feb 04, 2026 |
| Price on release | $0.757 |
| EPS estimate | -$0.108 |
| EPS actual | -$0.110 |
| EPS surprise | -2.23% |
| Date | Price |
|---|---|
| Jan 29, 2026 | $0.80 |
| Jan 30, 2026 | $0.81 |
| Feb 02, 2026 | $0.80 |
| Feb 03, 2026 | $0.752 |
| Feb 04, 2026 | $0.757 |
| Feb 05, 2026 | $0.600 |
| Feb 06, 2026 | $0.620 |
| Feb 09, 2026 | $0.578 |
| Feb 10, 2026 | $0.555 |
| 4 days before | -5.71% |
| 4 days after | -26.66% |
| On release day | -20.68% |
| Change in period | -30.84% |
| Release date | May 06, 2026 |
| Price on release | $0.477 |
| EPS estimate | -$0.0500 |
| EPS actual | -$0.0900 |
| EPS surprise | -80.00% |
| Date | Price |
|---|---|
| Apr 30, 2026 | $0.467 |
| May 01, 2026 | $0.467 |
| May 04, 2026 | $0.460 |
| May 05, 2026 | $0.461 |
| May 06, 2026 | $0.477 |
| May 07, 2026 | $0.293 |
| May 08, 2026 | $0.380 |
| May 11, 2026 | $0.343 |
| May 12, 2026 | $0.313 |
| 4 days before | 2.16% |
| 4 days after | -34.40% |
| On release day | -38.55% |
| Change in period | -32.98% |
Accuray Earnings Call Transcript Summary of Q1 2026
Accuray reported Q1 FY2026 revenues of $94.0M, down 7% year-over-year (down 9% on a constant currency basis). Product revenue was $37M (down 23% YoY), while service revenue—a higher-margin, recurring stream—was $57M (up 7% YoY), driven by contract revenue growth of 10% and installed base expansion. Product orders were ~$40M in the quarter (book-to-bill 1.1; trailing 12-month 1.2) and backlog was ~$396M (orders <30 months), representing ~18+ months of product revenue visibility. Gross margin declined to 28.3% (product gross margin 20.3%) mainly due to unfavorable product mix (geography and product), tariffs, and a one-time obsolescence charge. Operating expenses were $37.9M, including $2.8M of restructuring charges; adjusted EBITDA was a loss of $4.1M. Cash and equivalents were $64M; inventory rose as manufacturing ramps. Management launched a transformation plan and expects to reach a high single-digit adjusted EBITDA margin on a run-rate basis within 12 months and double-digit adjusted EBITDA margins over the medium to long term. Fiscal 2026 guidance was reiterated: revenue $471M–$485M and adjusted EBITDA $31M–$35M. Management expects H1 to be roughly 40% of full-year revenue and H2 about 60%, as some product demand shifts into the second half. Key near-term drivers to monitor: execution of the transformation plan, product order conversion from backlog (especially China and EIMEA), service revenue and contract pricing momentum, tariff mitigation efforts, and margin recovery as product mix improves.
Sign In
Buy ARAY